Effective and timely ways to address, screen, treat and code for substance use disorder in primary care medicine.  You will hear about how my family was personally affected by substance use disorder (SUD). Objectives include:

1. Recognize health disparities when treating substance use disorder. 
2. Illustrate effective ways to talk to your patients and patient's families about substance use disorder.
3. Apply the current and readily available screening tools in your practice.
4. Demonstrate how to appropriately treat patients with SUD beyond the need for a DEA(x) number and applying the appropriate ICD-10 codes.
5. Identify ways to reduce SUD stigma in patient assessment and care. 

In this 1-hour lecture will discuss the prevalence and diagnosis of Alcohol Use Disorder (AUD). Learners will build their understanding of medication-based and nonpharmacologic treatment options in an outpatient setting.  Objectives include:

1. Understand terminology and diagnostic criteria encompassing the spectrum of alcohol use.

2.Discuss outpatient management of alcohol withdrawal and appropriate risk stratification of patients who could be considered for outpatient detoxification.

3. List treatment strategies for Alcohol Use Disorder in the primary care setting with emphasis on Medication Assisted Treatment options.

4. Explore presentation of Alcohol Use Disorder in special populations and potential for health disparities.

On December 30, 2022, the DATA X-Waiver requirement to prescribe medication for opioid use disorder (MOUD) was eliminated by the federal government under the Mainstreaming Addiction Treatment (MAT) Act, section 1262 of the Consolidated Appropriations Act of 2023. Additionally, in 2022, the CDC updated guidance on opioids for acute and chronic pain.  This presentation will review the updated guidance and describe evidence-based practices to treat opioid use disorder, including with FDA-approved medication for opioid use disorder (MOUD), while exploring the impacts of socialized stigma and bias towards individuals with OUD and providing tools for prescribers to improve access to care including harm reduction.  Objectives include: 

1. Describe Opioid Use Disorder and discuss the new law eliminating the X waiver.?

2. Identify and apply 2022 CDC guidelines for prescribing opioids for acute, subacute, and/or chronic pain.?

3. Describe how to start buprenorphine for a patient with opioid use disorder.?

4. Examine how socialized stigma and biases affect care of people with substance use disorders.

5. Examine opportunities for improving access utilizing a harm-reduction & low barrier model.